Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Surgery Partners, Inc. before investing.

In this article, we go over a few key elements for understanding Surgery Partners, Inc.’s stock price such as:

• Surgery Partners, Inc.’s current stock price and volume
• Why Surgery Partners, Inc.’s stock price changed recently
• Upgrades and downgrades for SGRY from analysts
• SGRY’s stock price momentum as measured by its relative strength

About Surgery Partners, Inc. (SGRY)

Before we jump into Surgery Partners, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Want to learn more about Surgery Partners, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Surgery Partners, Inc..

Surgery Partners, Inc.’s Stock Price as of Market Close

As of July 08, 2026, 12:14 PM, CST, Surgery Partners, Inc.’s stock price was $16.310.

Surgery Partners, Inc. is down 5.01% from its previous closing price of $17.170.

During the last market session, Surgery Partners, Inc.’s stock traded between $16.220 and $17.000. Currently, there are approximately 128.37 million shares outstanding for Surgery Partners, Inc..

Surgery Partners, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Surgery Partners, Inc. Stock Price History

Surgery Partners, Inc.’s (SGRY) price is currently down 2.92% so far this month.

During the month of July, Surgery Partners, Inc.’s stock price has reached a high of $17.440 and a low of $16.220.

Over the last year, Surgery Partners, Inc. has hit prices as high as $24.100 and as low as $11.410. Year to date, Surgery Partners, Inc.’s stock is up 5.57%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Surgery Partners, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 07, 2026, there were 0 analysts who downgraded Surgery Partners, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Surgery Partners, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Surgery Partners, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Surgery Partners, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Surgery Partners, Inc. (SGRY) by visiting AAII Stock Evaluator.

Relative Price Strength of Surgery Partners, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 07, 2026, Surgery Partners, Inc. has a weighted four-quarter relative price strength of -2.96%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how Surgery Partners, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Surgery Partners, Inc. Stock Price: Bottom Line

As of July 8, 2026, Surgery Partners, Inc.’s stock price is $16.310, which is down 5.01% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Surgery Partners, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.